My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about CORT

Recent news which mentions CORT

< Previous 1 2 3 4 Next >
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Tickers CORT NEWS
Tags CORT Benzinga BZI/POD
From Benzinga
Earnings Scheduled For July 31, 2025
Tickers AAMI AAPL ABBV ACCO
Tags CCEC MTZ APTV
From Benzinga
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years
Tickers CORT NEWS
Tags Benzinga CORT Market News
From Benzinga
What's Driving the Market Sentiment Around Corcept Therapeutics?
Tickers CORT
Tags CORT BZI/SHORTHIST Short Sellers
From Benzinga
Here's How Much $100 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth Today
Tickers CORT NEWS
Tags Market News BZI/POD Trading Ideas
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Tickers CORT NEWS
Tags Benzinga CORT Market News
From Benzinga
Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study
Tickers CORT NEWS
Tags Health Care Market News News
From Benzinga
Here's How Much $1000 Invested In Corcept Therapeutics 5 Years Ago Would Be Worth Today
Tickers CORT NEWS
Tags Benzinga CORT Market News
From Benzinga
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years
Tickers CORT NEWS
Tags Benzinga CORT Market News
From Benzinga
How Do Investors Really Feel About Corcept Therapeutics?
Tickers CORT
Tags Short Ideas Trading Ideas Market News
From Benzinga
Assessing Corcept Therapeutics: Insights From 9 Financial Analysts
Tickers CORT
Tags CORT Analyst Ratings Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers CORT CTOR GCTK HSTM
Tags SNTI RFL TCMD
From Benzinga
Earnings Scheduled For May 5, 2025
Tickers ACEL ACM ADEA ADUS
Tags ALX CTRA HIMS
From Benzinga
Here's How Much $1000 Invested In Corcept Therapeutics 10 Years Ago Would Be Worth Today
Tickers CORT NEWS
Tags News Trading Ideas BZI/POD
From Benzinga
$1000 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth This Much Today
Tickers CORT NEWS
Tags CORT Benzinga News
From Benzinga
How Some Mid Cap Stocks Outshone The S&P 400's Dramatic Drop Last Week (Mar 31-Apr 4)
Tickers CELH COOP CORT GT
Tags why it's moving Market News News
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers BIAF CARM CORT CTXR
Tags CORT BZI/TFM ELTX
From Benzinga
Deep Dive Into Corcept Therapeutics Stock: Analyst Perspectives (7 Ratings)
Tickers CORT
Tags CORT Market News Analyst Ratings
From Benzinga
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast
Tickers CORT NEWS
Tags Analyst Ratings General Price Target
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Tickers ABVC BLUE CORT CTOR
Tags PCVX BLUE IBO
From Benzinga
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
Tickers COOP CORT NEWS NIVF
Tags Intraday Update TSHA Equities
From Benzinga
Mr. Cooper Group, Southern States Bancshares, Corcept Therapeutics And Other Big Stocks Moving Higher On Monday
Tickers BGS CELH COOP CORT
Tags Markets PHH CELH
From Benzinga
Nasdaq Tumbles Over 300 Points; Chicago PMI Rises In March
Tickers CORT DMN ICCT NEWS
Tags News PCVX Commodities
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers APLM APRE CORT CTOR
Tags STSS Benzinga APRE
From Benzinga
Earnings Scheduled For February 26, 2025
Tickers A AAOI AAP ABEV
Tags GOTU HCAT PERF
From Benzinga
Corcept Therapeutics' FDA-Approved Korlym Hits Main Goal In Cushing's Syndrome Patients With Difficult-To-Control Diabetes
Tickers CORT NEWS
Tags Benzinga General Stories That Matter
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Tickers ACHC ANIX ATEC CMAX
Tags ESLA Market News CTOR
From Benzinga
Earnings Preview: Corcept Therapeutics
Tickers CORT
Tags CORT BZI/EP Earnings
From Benzinga
Key Takeaways From Corcept Therapeutics Analyst Ratings
Tickers CORT
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
Tickers CORT NEWS TEVA
Tags News Expert Ideas Reiteration
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.